On 5 October 2012, South Africa’s Department of Health (DoH) announced the ARV tender for the period of 1 January 2013 to 31 December 2014. The DoH outlined the details of the tender in an open event on 10 October. The full tender can be found here:

On 17 October, TAC and MSF sent a joint letter to the Minister of Health Aaron Motsoaledi, which includes:

  • A request that a Ministerial Task Team to assess procurement procedures commence work immediately.
  • Concerns about the wording of the ARV tender specifying that the inclusion of FDCs will be based on economic considerations alone, given the current pricing of FDCs in South Africa’s private sector.
  • A reminder that not only are FDCs available in developing countries for as little as R69 (Ranbaxy), but that the benefits of FDCs far outweigh mere cost considerations.

The pdf version of the letter is available HERE